Position in LRMR
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$13,499,999
+$5,880,000 QoQ
Shares Held
3,000,000
+50.0% QoQ
Ownership
2.89%
of shares outstanding
% of Portfolio
2.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 73%
Shared 27%
None 0%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AIGH Capital Management LLC holds $149,698,985 across 14 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FENC |
Fennec Pharmaceuticals Inc.
|
2,486,038 | $26,724,908 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
|
2,795,797 | $24,910,550 | |
| 3 | ABEO |
Abeona Therapeutics Inc.
|
2,987,000 | $18,459,660 | |
| 4 | ARDX |
Ardelyx, Inc.
|
3,200,000 | $16,319,999 | |
| 5 | SPRB |
Spruce Biosciences, Inc.
|
250,000 | $13,500,000 | |
| 6 | VNDA |
Vanda Pharmaceuticals Inc.
|
2,044,169 | $12,510,313 | |
| 7 | PTHS |
Pelthos Therapeutics Inc.
|
329,098 | $9,300,309 | |
| 8 | PYPD |
PolyPid Ltd.
|
1,504,741 | $7,644,084 |
All Filings in LRMR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,499,999 | 3,000,000 | Shares | Other | 2026-04-30 | |
| 2025-12-31 | $7,619,999 | 2,000,000 | Shares | Other | 2026-02-02 | |
| 2025-09-30 | $3,230,000 | 1,000,000 | Shares | Other | 2025-10-31 | |
| No filing history on record for this holder in this stock. | ||||||